THE Therapeutic Goods
Administration (TGA) has
forewarned of anticipated short
supply of Bristol-Myers Squibb’s
etoposide in various forms.
The TGA has advised of
alternative injection products
available on the Australian
Register of Therapeutic Goods
from two other pharmaceutical
manufacturers, although there is no
alternative capsule form on offer.
Bristol-Myers Squibb has told
the TGA the shortage is due to an
“unexpected interruption in the
supply of the medicine’s active
pharmaceutical ingredient”.
More details at www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jun 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jun 16
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.